Aspiriant LLC’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,000
| Closed | -$549K | – | 303 |
|
|
2024
Q2 | $549K | Hold |
6,000
| – | – | 0.02% | 187 |
|
|
2024
Q1 | $544K | Buy |
6,000
+320
| +6% | +$29K | 0.02% | 190 |
|
|
2023
Q4 | $462K | Hold |
5,680
| – | – | 0.02% | 198 |
|
|
2023
Q3 | $454K | Buy |
+5,680
| New | +$454K | 0.02% | 188 |
|
|
2016
Q4 | – | Sell |
-29,495
| Closed | -$1.7M | – | 187 |
|
|
2016
Q3 | $1.7M | Sell |
29,495
-27,952
| -49% | -$1.61M | 0.17% | 78 |
|
|
2016
Q2 | $4.06M | Sell |
57,447
-3,105
| -5% | -$220K | 0.38% | 42 |
|
|
2016
Q1 | $3.48M | Buy |
+60,552
| New | +$3.48M | 0.33% | 46 |
|